A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
Open Access
- 1 June 2000
- Vol. 88 (11), 2505-2511
- https://doi.org/10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaBritish Journal of Cancer, 1999
- Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabineInvestigational New Drugs, 1996
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinomaAnnals of Oncology, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC)European Journal Of Cancer, 1993
- Reporting results of cancer treatmentCancer, 1981
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958